Skip to main content

Month: August 2024

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark

19th international market for Aureus branded products and 22nd market for all Avicanna products TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is pleased to announce that through its majority-owned subsidiary Santa Marta Golden Hemp SAS, the Company has completed the commercial export of Aureus branded products into Denmark. The commercial export of Aureus branded purified Cannabigerol (“CBG”), is a part of the Company’s portfolio of cannabinoid active pharmaceutical ingredients, marks the 19th international market for Aureus-branded products and also marks the 22nd market for all Avicanna products. This new market entry...

Continue reading

Ollie’s Bargain Outlet Holdings, Inc. Announces Second Quarter Fiscal 2024 Release Date and Conference Call Information

HARRISBURG, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) announced today that it will release its financial results for the second quarter of fiscal year 2024 on Thursday, August 29, 2024, before the market opens.   Following the release, at 8:30 a.m. Eastern Time, the Company’s management team will host a conference call to discuss its results. To access the live conference call, please pre-register here. Registrants will receive a confirmation with dial-in instructions. Interested parties can also listen to a live webcast or replay of the conference call by logging on to the Investor Relations section on the Company’s website at https://investors.ollies.us/. About Ollie’sWe are America’s largest retailer of closeout merchandise and excess inventory, offering Real Brands...

Continue reading

Unisync Reports Improving Q3 Financial Performance on Lower Revenues

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync”) (TSX:”UNI”) (OTC:“USYNF”) announces its unaudited financial results for the third quarter ended June 30, 2024 (“Q3 2024”). Unisync operates through two business units: Unisync Group Limited (“UGL”) with operations throughout Canada and the USA and majority owned Peerless Garments LP (“Peerless”), a domestic manufacturing operation based in Winnipeg, Manitoba. UGL is a leading customer-focused provider of corporate apparel, serving many leading Canadian and American iconic brands. Peerless specializes in the production and distribution of highly technical protective garments, including military operational clothing and accessories for a broad spectrum of Federal, Provincial and Municipal government departments and agencies. Results for Q3 2024...

Continue reading

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) — Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) highlights its low-CapEx plan for growing revenue in an updated corporate presentation now available at www.evomemedical.com/investor. The presentation, to be used during investor meetings planned for next month in New York, Vancouver, Montreal, and Toronto, highlights recent progress to stabilize the business and generate consistent positive Adjusted EBITDA1, as well as a fresh growth strategy based on leveraging the Biodex® brand of its core business, Biodex Medical Systems, Inc. (“Biodex”), and its more than 15,000 customers served over the past 30 years. The revenue strategy...

Continue reading

ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements

• Executed Global Licensing Agreements that could provide up to $292 million in income • Received Cash Milestone Incomes of $116,000 • Achieved Significant Improvements in Earnings • Obtained Multiple Patents and FDA Approvals FREMONT, CA, Aug. 15, 2024 (GLOBE NEWSWIRE) —  ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, is pleased to announce its financial results and key operational highlights for the second quarter ended June 30, 2024. Key Financial and Operational Highlights: 1. Significant Global Licensing Agreements:  – Vitargus® Licensing: Along with our subsidiary, BioFirst Corporation, we secured licensing agreements with ForSeeCon Eye Corporation that have the potential to provide up to a total of $187...

Continue reading

Cartier intersects 11.2 g/t Au over 2.0 m on VG9 Target

Highlights of this press release:New type of high-grade gold mineralization for VG9 Target (FIGURE 1):11.2 g/t Au / 2.0 m including 20.2 g/t Au / 1.0 m 9.1 g/t Au / 1.0 mThe VG9 Target mineralization begins at surface These results are found within the Larder Lake – Cadillac Fault Zone, well known for its many important mines in Canada, comprising several types of mineralization; which are found at varying distances from each otherVAL D’OR, Quebec, Aug. 15, 2024 (GLOBE NEWSWIRE) — Cartier Resources Inc. (TSXV: ECR, FSE: 6CA) (“Cartier” or the “Company”) announces results from the ongoing drill program for the Chimo Mine Project (FIGURE 2). The Project comprises the Chimo Mine and East Cadillac properties, the latter of which was acquired on April 7, 2022. Cartier began exploring of this part of the East...

Continue reading

Atlantic International Corp. Reports Over $104 Million in Q2 Revenue and 17% Revenue Growth for the 2nd Quarter

Growth Follows Atlantic’s Completed Merger with Lyneer Staffing Solutions, Creating a Top 40 U.S. Staffing Firm with Over $400 Million in Annual Revenue ENGLEWOOD CLIFFS, N.J., Aug. 15, 2024 (GLOBE NEWSWIRE) — Atlantic International Corp. (“Atlantic”) (OTC: ATLN), a leading provider of strategic staffing outsourced services and workforce solutions, today announced its financial results for the second quarter ended June 30, 2024. “Atlantic achieved substantial revenue growth in the second quarter, which was our first reporting period as a newly public company. We are extremely proud of all our employees who work every day to deliver e-commerce logistics on time and at the right price for our customers,” said Jeffrey Jagid, Chief Executive Officer. Key Q2 Financial Highlights: – Revenue: Atlantic International Corp. reported...

Continue reading

New Data from Fumed Silica Reactor Commissioning Shows Additional Significant Drop in Both Energy Use and Carbon Footprint

Up to 92.0% less energy is required to produce fumed silica in one step compared to conventional industry processes Up to 99.9% less CO2 emissions associated with the production process compared to conventional industry processes.MONTREAL, Aug. 15, 2024 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in the green engineering of silica and silicon-based materials is pleased to share new data from recent updated process modelization work. This work was accomplished by technology supplier PyroGenesis Canada Inc. (TSX: PYR, OTCQX: PYRGF, FRA: 8PY) (“PyroGenesis”) during the ongoing commissioning of HPQ Silica Polvere Inc. (“HSPI”) [1] Fumed Silica Reactor (“FSR”) pilot plant. The new data highlights the commercial and environmental impact advantages...

Continue reading

Rubicon Organics Reports Q2 2024 Financial Results

Delivered record net revenue of $12.1 million (7% increase) for the three months ended June 30, 2024 Delivered $21.0 million net revenue (5% increase) for the six months ended June 30, 2024 Adjusted EBITDA1 of $0.9 million for the three months ended June 30, 2024 Operating cash flow of $1.1 million for the three months ended June 30, 2024 Free cash flow2 of $0.7 million for the three months ended June 30, 2024 Number one premium licenced producer across all categories3 2.0%4 national market share of flower and pre-rolls for the three and six months ended June 30, 2024 5.7%5 and 6.1%6 national market share of premium flower and pre-rolls for the three and six months ended June 30, 2024 Wildflower™ is the number one topical brand in Canada with market share of 28%7 for the six months ended June 30, 2024 29.9%8 and 26.8%9 national market...

Continue reading

Cellebrite Announces Second-Quarter 2024 Results

Revenue of $95.7 million, 25% year-over-year increase primarily due to27% growth in subscription revenue;ARR of $345.9 million, up 26% year-over-year;Adjusted EBITDA of $21.6 million, 22.6% adjusted EBITDA margin;Company increases 2024 outlook for revenue and adjusted EBITDA, and raises midpoint for ARR TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence (“DI”) solutions for the public and private sectors, today announced financial results for the three and six months ending June 30, 2024. “Our outstanding second-quarter 2024 performance was highlighted by significant strategic progress and strong growth in ARR, revenue and adjusted EBITDA,” said Yossi Carmil, Cellebrite’s CEO. “During the past several months, we delivered against our top...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.